基本信息
浏览量:860
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Masatsugu Hori MD, PhD.is currently the President of Osaka Medical Center for Cancer and Cardiovascular Diseases. He graduated Osaka University School of Medicine in 1970 and trained as a resident at Osaka University Hospital for three years. He worked at Albert Einstein College of Medicine, Yeshiva University in N.Y., USA as a Visiting Assistant Professor for two years (1979-1981) and engaged in the research work ondiastolic function of the heart. He was appointed as the chief of cardiology, Osaka University, School of Medicine in 1989, and Professor of Medicine, Osaka University in 1997.
He investigated the role of thromboembolism in small coronary arteries and found the coronary hyperemic response after coronary microsphere-embolization, attributable to endogenous adenosine release. He first investigated the nonreflow in patients with acute myocardial infarction by contrast echo technique. He observed the enhanced adenosine production in ischemic preconditioning due to increased activity of 5’-nucleotidase induced by PKC activation which affords cellular protection and improvement of coronary microcirculation. He also found that late ischemic preconditioning is attributable to enhanced Mn-SOD production. Recently, he investigated signal transduction in cardiac hypertrophy and elucidated the molecular mechanism of activation of HB-EGF and the signaling pathway in ASK-1 regulating hypertrophy and apoptosis.
In clinical research, he conducted a large registry study for acute coronary syndrome (OACIS) in which classic and genetic risk factors for ischemic heart disease were elucidated in Japanese population. He also conducted several clinical trials; β-blocker for chronic heart failure (MUCHA/J-CHF trials) and aspirin for atrial fibrillation (JAST trial), antithrombin inhibitor (dabigatran/RE-LY trial substudy) and Xa inhibitor (rivaroxaban, J -ROCKET AF) for non-valvular AF. It should be noted that he contributed to the initial set-up of cardiac transplantation in Japan.
He received several awards for his scientific achievements. He has served for major scientific societies as the board of directors. He has been for ten years the chair of the Scientific Committee in Japanese Circulation Society, and contributed to writing many clinical guidelines for cardiovascular diseases. He hosted several national international scientific meetings, e.g. the 73th Annual Scientific Meeting of the Japanese Circulation Society and the 104th Annual Meeting of Internal Medicine. Recently, he organized ISHR World Congress as a chair and president of the society. He also serves for the scientific board as a member of the Science Council of Japan. He published a total 520 papers in the international journals.
研究兴趣
论文共 985 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Makiko Maeda,Douglas Humber,Eisuke Hida, Tomohito Ohtani, Guannan Wang, Tong Wu, Shiori Takeda, Jacinta N. Situ, Jun Hayashi, Shinpei Nonen,Toshihiro Takeda,Hiroshi Okamoto,
PloS oneno. 3 (2024): e0299510-e0299510
AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE (2023): 100292-100292
Tsutomu Kawai,Daisaku Nakatani, Tetsuya Watanabe, Takahisa Yamada,Takashi Morita, Yasuhiko Sakata, Shungo Hikoso, Hiroya Mizuno,Shinichiro Suna,Tetsuhisa Kitamura,Katsuki Okada,Tomoharu Dohi,
Current problems in cardiologyno. 11 (2022): 101326-101326
加载更多
作者统计
#Papers: 886
#Citation: 42331
H-Index: 100
G-Index: 173
Sociability: 8
Diversity: 4
Activity: 19
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn